Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Bozeman Deaconess Hospital
mi
from
Bozeman, MT
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Bozeman Deaconess Hospital
mi
from
Bozeman, MT
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Tri-Cities Cancer Center
mi
from
Kennewick, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Tri-Cities Cancer Center
mi
from
Kennewick, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
SCCA at EvergreenHealth
mi
from
Kirkland, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
SCCA at EvergreenHealth
mi
from
Kirkland, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Skagit Valley Hospital
mi
from
Mount Vernon, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Skagit Valley Hospital
mi
from
Mount Vernon, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Olympic Medical Center
mi
from
Port Angeles, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Olympic Medical Center
mi
from
Port Angeles, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Group Health Cooperative
mi
from
Redmond, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Group Health Cooperative
mi
from
Redmond, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Swedish Cancer Institute
mi
from
Seattle, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Click here to add this to my saved trials
Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
An Open-Label, Randomized, Phase II/III Trial of Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  3/8/2016
Peregrine Pharmaceuticals Investigational Site
mi
from
Bakersfield, CA
Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
An Open-Label, Randomized, Phase II/III Trial of Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 3/8/2016
Peregrine Pharmaceuticals Investigational Site
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
An Open-Label, Randomized, Phase II/III Trial of Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  3/8/2016
Peregrine Pharmaceuticals Investigational Site
mi
from
Tinley Park, IL
Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
An Open-Label, Randomized, Phase II/III Trial of Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 3/8/2016
Peregrine Pharmaceuticals Investigational Site
mi
from
Tinley Park, IL
Click here to add this to my saved trials
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
Status: Enrolling
Updated:  3/10/2016
UNC Hospitals
mi
from
Chapel Hill, NC
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
Status: Enrolling
Updated: 3/10/2016
UNC Hospitals
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Ocean Medical Center
mi
from
Brick, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Ocean Medical Center
mi
from
Brick, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Bayshore Community Hospital
mi
from
Holmdel, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Bayshore Community Hospital
mi
from
Holmdel, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Southern Ocean Medical Center
mi
from
Manahawkin, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Southern Ocean Medical Center
mi
from
Manahawkin, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Riverview Medical Center
mi
from
Red Bank, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Riverview Medical Center
mi
from
Red Bank, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Somerset Medical Center
mi
from
Somerville, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Somerset Medical Center
mi
from
Somerville, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Cooper Hospital University Medical Center
mi
from
Camden, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Cooper Hospital University Medical Center
mi
from
Camden, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer
Status: Enrolling
Updated:  3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer
Status: Enrolling
Updated: 3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Chemotherapy in Treating Patients With Breast Cancer
Phase I/II Clinical and Pharmacological Study of Liposomal Annamycin in Anthracycline-Resistant Breast Cancer
Status: Enrolling
Updated:  3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Chemotherapy in Treating Patients With Breast Cancer
Phase I/II Clinical and Pharmacological Study of Liposomal Annamycin in Anthracycline-Resistant Breast Cancer
Status: Enrolling
Updated: 3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression
Phase I/II Study Of Herceptin Combined With OSI-774 In The First-Line Treatment Of Metastatic Breast Cancer Associated With HER2/Neu Overexpression
Status: Enrolling
Updated:  3/11/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression
Phase I/II Study Of Herceptin Combined With OSI-774 In The First-Line Treatment Of Metastatic Breast Cancer Associated With HER2/Neu Overexpression
Status: Enrolling
Updated: 3/11/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Dana-Farber Cancer Center
mi
from
Boston, MA
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Dana-Farber Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Karmanos Cancer Center
mi
from
Detroit, MI
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Karmanos Cancer Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated:  3/14/2016
University of Indiana
mi
from
Indianapolis, IN
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated: 3/14/2016
University of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Washington University
mi
from
St. Louis, MO
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated:  3/14/2016
University of California at San Francisco
mi
from
San Francisco, CA
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination With Trastuzumab With or Without Cyclophosphamide in Patients With Advanced HER2 Positive Breast Cancer
Status: Enrolling
Updated: 3/14/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery
A Phase I, Open Label, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetic Properties of the Combination of Cilengitide and Paclitaxel in Patients With Advanced Solid Malignancies
Status: Enrolling
Updated:  3/14/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery
A Phase I, Open Label, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetic Properties of the Combination of Cilengitide and Paclitaxel in Patients With Advanced Solid Malignancies
Status: Enrolling
Updated: 3/14/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery
A Phase I, Open Label, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetic Properties of the Combination of Cilengitide and Paclitaxel in Patients With Advanced Solid Malignancies
Status: Enrolling
Updated:  3/14/2016
Mayo Clinic Florida
mi
from
Jacksonville, FL
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery
A Phase I, Open Label, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetic Properties of the Combination of Cilengitide and Paclitaxel in Patients With Advanced Solid Malignancies
Status: Enrolling
Updated: 3/14/2016
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery
A Phase I, Open Label, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetic Properties of the Combination of Cilengitide and Paclitaxel in Patients With Advanced Solid Malignancies
Status: Enrolling
Updated:  3/14/2016
The Mayo Clinic
mi
from
Rochester, MN
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery
A Phase I, Open Label, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetic Properties of the Combination of Cilengitide and Paclitaxel in Patients With Advanced Solid Malignancies
Status: Enrolling
Updated: 3/14/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer
Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer: A Randomized Trial
Status: Enrolling
Updated:  3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer
Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer: A Randomized Trial
Status: Enrolling
Updated: 3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Breastlink Med Group Inc
mi
from
Long Beach, CA
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Breastlink Med Group Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Georgia Cancer Specialists
mi
from
Atlanta, GA
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Georgia Cancer Specialists
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Montana Cancer Institute Foundation
mi
from
Missoula, MT
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Montana Cancer Institute Foundation
mi
from
Missoula, MT
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Clinical Research Alliance, Inc.
mi
from
Lake Success, NY
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Clinical Research Alliance, Inc.
mi
from
Lake Success, NY
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Oncology Hematology Care
mi
from
Cincinnati, OH
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Oncology Hematology Care
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Guthrie Clinic, Ltd.
mi
from
Sayre, PA
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Guthrie Clinic, Ltd.
mi
from
Sayre, PA
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Santee Hematology Oncology, Inc.
mi
from
Sumter, SC
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Santee Hematology Oncology, Inc.
mi
from
Sumter, SC
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Arizona Cancer Center
mi
from
Tucson, AZ
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
The Angeles Clinic & Research Institute
mi
from
Los Angeles, CA
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
The Angeles Clinic & Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Florida Cancer Specialists
mi
from
West Coast, FL
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Florida Cancer Specialists
mi
from
West Coast, FL
Click here to add this to my saved trials
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated:  3/14/2016
Peachtree Hematology-Oncology Consultants
mi
from
Atlanta, GA
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
A Phase II, Randomized, Multicenter Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Status: Enrolling
Updated: 3/14/2016
Peachtree Hematology-Oncology Consultants
mi
from
Atlanta, GA
Click here to add this to my saved trials